These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6687345)

  • 1. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose.
    Cooper DS; Goldminz D; Levin AA; Ladenson PW; Daniels GH; Molitch ME; Ridgway EC
    Ann Intern Med; 1983 Jan; 98(1):26-9. PubMed ID: 6687345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retrospective analysis of 18 cases with agranulocytosis induced by antithyroid drugs].
    Dai W; Zhang J; Zhan Z; Xu B; Jin H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):226-9. PubMed ID: 11367711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects related to antithyroid drugs and their dose regimen.
    Romaldini JH; Werner MC; Bromberg N; Werner RS
    Exp Clin Endocrinol; 1991 May; 97(2-3):261-4. PubMed ID: 1915643
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracil.
    Yoshimura Noh J; Inoue K; Suzuki N; Yoshihara A; Fukushita M; Matsumoto M; Imai H; Hiruma S; Ichikawa M; Koshibu M; Sankoda A; Hirose R; Watanabe N; Sugino K; Ito K
    Endocr J; 2024 Jul; 71(7):695-703. PubMed ID: 38710619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of 18 cases of antithyroid drug (ATD)-induced agranulocytosis.
    Dai WX; Zhang JD; Zhan SW; Xu BZ; Jin H; Yao Y; Xin WC; Bai Y
    Endocr J; 2002 Feb; 49(1):29-33. PubMed ID: 12008747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatotoxicity from antithyroid drugs.
    Vitug AC; Goldman JM
    Horm Res; 1985; 21(4):229-34. PubMed ID: 4007783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment.
    Kobayashi S; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Ohye H; Suzuki M; Yoshihara A; Iwaku K; Sugino K; Ito K
    Thyroid; 2014 May; 24(5):796-801. PubMed ID: 24341564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed anithyroid drug-induced agranulocytosis.
    Mutharasan P; Oatis W; Kwaan H; Molitch M
    Endocr Pract; 2012; 18(4):e69-72. PubMed ID: 22297058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects related to thionamide drugs and their dose regimen.
    Werner MC; Romaldini JH; Bromberg N; Werner RS; Farah CS
    Am J Med Sci; 1989 Apr; 297(4):216-9. PubMed ID: 2523194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The occurrence of agranulocytosis due to antithyroid drugs in a cohort of patients with Graves disease treated with radioactive iodine 131I during 14 years].
    Cepková J; Gabalec F; Svilias I; Horáček J
    Vnitr Lek; 2014 Oct; 60(10):832-6. PubMed ID: 25382005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agranulocytosis and antithyroid drugs.
    Rosove MH
    West J Med; 1977 May; 126(5):339-43. PubMed ID: 867981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily.
    Takata K; Kubota S; Fukata S; Kudo T; Nishihara E; Ito M; Amino N; Miyauchi A
    Thyroid; 2009 Jun; 19(6):559-63. PubMed ID: 19445623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan.
    Nakamura H; Miyauchi A; Miyawaki N; Imagawa J
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4776-83. PubMed ID: 24057289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Antithyroid Drug-Induced Agranulocytosis in Patients with Hyperthyroidism: A Retrospective Analysis of 114 Cases in a Single Institution in China Involving 9690 Patients Referred for Radioiodine Treatment Over 15 Years.
    Yang J; Zhu YJ; Zhong JJ; Zhang J; Weng WW; Liu ZF; Xu Q; Dong MJ
    Thyroid; 2016 May; 26(5):627-33. PubMed ID: 26867063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring.
    Tajiri J; Noguchi S; Murakami T; Murakami N
    Arch Intern Med; 1990 Mar; 150(3):621-4. PubMed ID: 2310281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent agranulocytosis induced by two different antithyroid agents.
    Chen B; Lang R; Jutrin Y; Ravid M
    Med J Aust; 1983 Jul; 2(1):38-9. PubMed ID: 6865827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves' disease.
    Tsuboi K; Ueshiba H; Shimojo M; Ishikawa M; Watanabe N; Nagasawa K; Yuasa R; Yoshino G
    Endocr J; 2007 Feb; 54(1):39-43. PubMed ID: 17053291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithyroid drugs.
    Cooper DS
    N Engl J Med; 2005 Mar; 352(9):905-17. PubMed ID: 15745981
    [No Abstract]   [Full Text] [Related]  

  • 19. Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease.
    Watanabe N; Narimatsu H; Noh JY; Yamaguchi T; Kobayashi K; Kami M; Kunii Y; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E49-53. PubMed ID: 22049174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antithyroid drug-induced agranulocytosis. A rare but dreaded condition].
    Lehtihet M; Zedenius J; Helldén A; Axelsson R; Calissendorff J
    Lakartidningen; 2009 Oct 7-13; 106(41):2607-8, 2610-1. PubMed ID: 19927925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.